Viridian Therapeutics Inc. Skyrocketed
Mon, Aug 15, 2022 at 07:00 PM
Viridian Therapeutics Inc. (VRDN:NASDAQ) rocketted at $22, a gain of 49.4%. On Mon, Aug 15, 2022, VRDN:NASDAQ hit a New 2-Week High of $22. The stock appeared on our News Catalysts scanner on Mon, Aug 15, 2022 at 04:33 PM in the 'PUBLIC OFFERING' category. From Mon, Aug 01, 2022, the stock recorded 70.00% Up Days and 63.64% Green Days
About Viridian Therapeutics Inc. (VRDN:NASDAQ)
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease.
Top 10 Gainers:
- Magic Empire Global Limited (MEGL:NASDAQ), 115.69%
- MiNK Therapeutics Inc. (INKT:NASDAQ), 98.83%
- Regis Corporation (RGS:NYSE), 75.15%
- Team, Inc. (TISI:NYSE), 57.79%
- Viridian Therapeutics Inc. (VRDN:NASDAQ), 49.36%
- Terns Pharmaceuticals Inc. (TERN:NASDAQ), 45.7%
- GigaMedia Limited (GIGM:NASDAQ), 41.46%
- Revlon, Inc. (REV:NYSE), 30.64%
- Qualtek Services Inc Cl A (QTEK:NASDAQ), 28.82%
- RCM Technologies, Inc. (RCMT:NASDAQ), 26.82%